Project Details
Description
This observational matched prospective study aims to assess the effectiveness and adherence for inclisiran in combination with Lipid lowering therapies or Lipid lowering treatments (LLT) compared to other LLTs under conditions of routine clinical practice.
| Acronym | VICTORION REAL |
|---|---|
| Status | Active |
| Effective start/end date | 12/09/22 → 1/04/27 |
Collaborative partners
- Ministry of Health and Prevention
- Novartis Pharmaceuticals Corporation (lead)
- Abu Dhabi Health Services Company
- Dubai Health Authority
- Emirates Health Services
Keywords
- primary hypercholesterolemia
- mixed dyslipidemia
- real-world study
- inclisiran
- lipid-lowering therapy
- LLT
- ASCVD
- Hyperlipidemias
- Lipid Metabolism Disorders
- Metabolic Diseases
- Hypercholesterolemia
- Dyslipidemias
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.